Presentation at OPT 2022 to highlight AATD program, including reduction of liver aggregates with repeat…
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a…
BASKING RIDGE, N.J., March 15, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
MONTRÉAL, March 15, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and…
Photo 1 Reception at New Trusting Heart Blood Center – Raleigh, North Carolina Photo 2…
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
ENA Respiratory begins influenza challenge study for fast-acting nasal spray INNA-051, designed to boost innate…
Updates on preclinical data and the clinical development plan will be presented at the Muscular…
SEATTLE, March 15, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Study conducted with Tufts Medical Center represents a breakthrough showing that Microdose Array Print (MAP™)…
The Company has moved from Cambridge, MA to a new, larger space in the Seaport…
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
MIAMI, March 15, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical…
– Dr. Dias is a biotech and pharma industry executive with more than 20 years…
Ovid executing on its strategy to build a leading epilepsy pipeline OV329 expected to enter…
Conference Provides First Exposure of EU and UK AD Experts to INmune Bio’s Approach of…
SEATTLE and VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
NCI achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of…
ROCKVILLE, Md., March 15, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the…